Galmed Pharmaceuticals (GLMD) Shares Outstanding (Diluted Average) (2013 - 2025)

Galmed Pharmaceuticals' Shares Outstanding (Diluted Average) history runs 13 years deep, the most recent figure standing at $4.3 million for Q4 2025.

• In Q4 2025, Shares Outstanding (Diluted Average) rose 363.17% year-over-year to $4.3 million; the TTM figure through Dec 2025 stood at $4.3 million (up 363.17% YoY), while the FY2025 annual figure was $4.3 million, up 363.17% from the prior year.
• Shares Outstanding (Diluted Average) was $4.3 million for Q4 2025 at Galmed Pharmaceuticals, up from $1470.0 in the prior quarter.
• In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $25.1 million in Q2 2021 to a low of $1250.0 in Q2 2025.
• Historically, Shares Outstanding (Diluted Average) has averaged $4.4 million across 5 years, with a median of $769587.5 in 2024.
• The sharpest annual moves came in 2022 and 2025: Shares Outstanding (Diluted Average) slumped 99.98% in 2022, then soared 363.17% in 2025.
• A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $1.6 million in 2021, then plunged by 91.48% to $139682.0 in 2022, then soared by 65.23% to $230795.0 in 2023, then jumped by 303.31% to $930822.0 in 2024, then soared by 363.17% to $4.3 million in 2025.
• The last three Shares Outstanding (Diluted Average) figures came in at $4.3 million (Q4 2025), $1470.0 (Q3 2025), and $1250.0 (Q2 2025), per Business Quant data.